Atlas Trials

A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

Clinical trial NCT01863953 · COMPLETED

Trial details

NCT number
NCT01863953
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GlaucomaOcular Hypertension
Start date
2013-06-01
Primary completion
2013-12-01
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.